159 related articles for article (PubMed ID: 23708917)
1. Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.
Taghavi MS; Akbarzadeh A; Mahdian R; Azadmanesh K; Javadi G
In Vitro Cell Dev Biol Anim; 2013 Jun; 49(6):465-72. PubMed ID: 23708917
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12.
Floros KV; Thomadaki H; Lallas G; Katsaros N; Talieri M; Scorilas A
Ann N Y Acad Sci; 2003 Dec; 1010():153-8. PubMed ID: 15033711
[TBL] [Abstract][Full Text] [Related]
3. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Korbakis D; Scorilas A
Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053
[TBL] [Abstract][Full Text] [Related]
4. Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
Stegh AH; DePinho RA
Cell Cycle; 2011 Jan; 10(1):33-8. PubMed ID: 21200141
[TBL] [Abstract][Full Text] [Related]
5. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
Stegh AH; Kesari S; Mahoney JE; Jenq HT; Forloney KL; Protopopov A; Louis DN; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10703-8. PubMed ID: 18669646
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
7. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Thomadaki H; Floros KV; Scorilas A
Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
[TBL] [Abstract][Full Text] [Related]
8. What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator.
Stegh AH; Chin L; Louis DN; DePinho RA
Cell Cycle; 2008 Sep; 7(18):2833-9. PubMed ID: 18769159
[TBL] [Abstract][Full Text] [Related]
9. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.
Stegh AH; Kim H; Bachoo RM; Forloney KL; Zhang J; Schulze H; Park K; Hannon GJ; Yuan J; Louis DN; DePinho RA; Chin L
Genes Dev; 2007 Jan; 21(1):98-111. PubMed ID: 17210792
[TBL] [Abstract][Full Text] [Related]
10. Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12.
Kontos CK; Avgeris M; Vassilacopoulou D; Ardavanis A; Scorilas A
Curr Pharm Biotechnol; 2018; 19(13):1064-1075. PubMed ID: 30417787
[TBL] [Abstract][Full Text] [Related]
11. GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.
Chou CH; Chou AK; Lin CC; Chen WJ; Wei CC; Yang MC; Hsu CM; Lung FW; Loh JK; Howng SL; Hong YR
Cell Cycle; 2012 Feb; 11(3):532-42. PubMed ID: 22262180
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells.
Hong Y; Yang J; Wu W; Wang W; Kong X; Wang Y; Yun X; Zong H; Wei Y; Zhang S; Gu J
Biochim Biophys Acta; 2008 Nov; 1782(11):649-57. PubMed ID: 18930135
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.
Lee MT; Ho SM; Tarapore P; Chung I; Leung YK
Neoplasia; 2013 Nov; 15(11):1262-71. PubMed ID: 24339738
[TBL] [Abstract][Full Text] [Related]
16. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
[TBL] [Abstract][Full Text] [Related]
17. Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells.
Miao BP; Zhang RS; Yang G; Sun JJ; Tang YY; Liang WF; Liu T; Wen Z; Yang PC; Nie GH
Arch Biochem Biophys; 2018 May; 646():72-79. PubMed ID: 29621521
[TBL] [Abstract][Full Text] [Related]
18. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
19. Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.
Stegh AH; Brennan C; Mahoney JA; Forloney KL; Jenq HT; Luciano JP; Protopopov A; Chin L; Depinho RA
Genes Dev; 2010 Oct; 24(19):2194-204. PubMed ID: 20837658
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.
Adamopoulos PG; Kontos CK; Tsiakanikas P; Scorilas A
Cancer Lett; 2016 Apr; 373(1):119-129. PubMed ID: 26797417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]